About Emulate
Emulate is a company based in Boston (United States) founded in 2013 by Daniel Levner.. Emulate has raised $204.49 million across 9 funding rounds from investors including LabCorp, Cedars Sinai and HHS. Emulate offers products and services including Organ-Chip, Software Platform, Consumables, and BioKits. Emulate operates in a competitive market with competitors including CN Bio, AxoSim, Mimetas, Nortis and NETRI, among others.
- Headquarter Boston, United States
- Founders Daniel Levner
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$204.49 M (USD)
in 9 rounds
-
Latest Funding Round
$82 M (USD), Series E
Sep 07, 2021
-
Investors
LabCorp
& 14 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emulate
Emulate offers a comprehensive portfolio of products and services, including Organ-Chip, Software Platform, Consumables, and BioKits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Microfluidic tool for simulating human organ functions in research
Platform for managing and analyzing Organ-Chip experiment data
Materials supporting Organ-Chip operations in laboratory settings
Kits for specific applications like disease modeling
Unlock access to complete
Unlock access to complete
Funding Insights of Emulate
Emulate has successfully raised a total of $204.49M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $82 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series E — $82.0M
-
First Round
First Round
(28 Jul 2014)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series E - Emulate | Valuation | Perceptive Advisors , Northpond Ventures |
|
| Mar, 2020 | Amount | Debt – Conventional - Emulate | Valuation |
investors |
|
| Aug, 2019 | Amount | Series C - Emulate | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Emulate
Emulate has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LabCorp, Cedars Sinai and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology and defense sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emulate
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Emulate
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emulate Comparisons
Competitors of Emulate
Emulate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CN Bio, AxoSim, Mimetas, Nortis and NETRI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Organ-on-a-chip platforms are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based organ-on-a-chip models for drug evaluation are developed.
|
|
| domain | founded_year | HQ Location |
Small human tissue segments are generated in microfluidic chips.
|
|
| domain | founded_year | HQ Location |
Microfluidic devices are developed for industrial applications and brain-on-a-chip models.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Emulate
Frequently Asked Questions about Emulate
When was Emulate founded?
Emulate was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Emulate located?
Emulate is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Emulate a funded company?
Emulate is a funded company, having raised a total of $204.49M across 9 funding rounds to date. The company's 1st funding round was a Series C of $27.99M, raised on Jul 28, 2014.
What does Emulate do?
The company was founded in 2013 in Boston, United States, and operates in the biotechnology sector focused on drug development. In vitro models, including organ-chips for the liver, intestine, kidney, and other organs, are developed to simulate human physiology. These models feature tiny channels lined with living human cells and tissues for predicting responses. Culture modules and analytical software applications are also provided to support research operations.
Who are the top competitors of Emulate?
Emulate's top competitors include CN Bio, Cellbox Labs and Nortis.
What products or services does Emulate offer?
Emulate offers Organ-Chip, Software Platform, Consumables, and BioKits.
Who are Emulate's investors?
Emulate has 15 investors. Key investors include LabCorp, Cedars Sinai, HHS, Perceptive Advisors, and ATEL Capital Group.